Topical Nitroglycerine in Perniosis/Chilblains.

The treatment of perniosis is largely inadequate. The success rate of 0.2% nitroglycerine ointment is demonstrated in the present series. Twenty-two patients clinically diagnosed with severe perniosis were prescribed the topical vasodilator nitroglycerine. Digital photography and patient self-report of the clinical appearance, degree of irritation, and pain and soreness of the lesions were assessed on a 3-point scale to assess therapeutic response. A total of 18 of the 22 patients had regression of the lesions within the first week of treatment and complete regression in 2 weeks. Of these patients, 2 who experienced a relapse were successfully treated with another course of topical nitroglycerine. Two of 22 patients had regression of the lesions during the second week and complete regression in another week. Response was delayed in patients with a longer duration of disease. Topical 0.2% nitroglycerine ointment may be a promising alternative treatment option in perniosis.
AuthorsPrashant Verma
JournalSkinmed (Skinmed) 2015 May-Jun Vol. 13 Issue 3 Pg. 176-7 ISSN: 1540-9740 [Print] United States
PMID26380502 (Publication Type: Journal Article)
Chemical References
  • Ointments
  • Vasodilator Agents
  • Nitroglycerin
  • Administration, Topical
  • Adolescent
  • Chilblains (drug therapy)
  • Cohort Studies
  • Female
  • Humans
  • Male
  • Nitroglycerin (therapeutic use)
  • Ointments
  • Treatment Outcome
  • Vasodilator Agents (therapeutic use)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: